2,871 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Argus Investors Counsel Inc.

Argus Investors Counsel Inc. bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,871 shares of the company’s stock, valued at approximately $224,000.

Several other large investors have also made changes to their positions in the company. LGT Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at $26,000. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at $26,000. Darwin Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at $31,000. Finally, Continuum Advisory LLC grew its stake in shares of GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Up 0.3 %

NASDAQ:GEHC opened at $87.17 on Thursday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The stock has a 50-day simple moving average of $83.14 and a 200 day simple moving average of $85.15. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.55. The company has a market capitalization of $39.83 billion, a price-to-earnings ratio of 23.95, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.